PlaqueTec, a company identifying endotype-specific biomarkers to advance precision medicine for coronary artery disease (CAD), today announced that it has received the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) approval to continue its BIOPATTERN trial following recruitment of the first ten patients with CAD.
HHS names inaugural chief competition officer
The Department of Health and Human Services will name Stacy Sanders as its new chief competition officer, the agency announced Monday. The new position was